{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:02Z","timestamp":1792788182403,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Sciences Foundation of China","award":["82305329"],"award-info":[{"award-number":["82305329"]}]},{"name":"the National Sciences Foundation of China","award":["82505683"],"award-info":[{"award-number":["82505683"]}]},{"name":"the National Natural Science Foundation of Hunan Province","award":["2024jj6343"],"award-info":[{"award-number":["2024jj6343"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of Hunan Province","award":["2026jj81078"],"award-info":[{"award-number":["2026jj81078"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the project of Hunan Provincial Department of Education","award":["25A0290"],"award-info":[{"award-number":["25A0290"]}]},{"name":"the project of Hunan provincial health commission","award":["20253881"],"award-info":[{"award-number":["20253881"]}]},{"name":"the project of Hunan provincial health commission","award":["20257618"],"award-info":[{"award-number":["20257618"]}]},{"name":"the project of Hunan provincial administration of traditional chinese medicine","award":["B2024006"],"award-info":[{"award-number":["B2024006"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the project of Hunan provincial postgraduate innovation","award":["CX20251197"],"award-info":[{"award-number":["CX20251197"]}]},{"name":"Chinese Academy of Engineering Academician Liang Liu\u2019s Workstation of Hunan University of Chinese Medicine","award":["22YS001"],"award-info":[{"award-number":["22YS001"]}],"id":[{"id":"https:\/\/ror.org\/00z3yke57","id-type":"ROR","asserted-by":"crossref"}]},{"name":"First-class Discipline Construction Project of Hunan University of Chinese Medicine","award":["22JBZ011"],"award-info":[{"award-number":["22JBZ011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08635-8","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:15:41Z","timestamp":1783703741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chelerythrine: a novel candidate for targeting miR-21\/PTEN\/PI3K\/AKT in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"3","key":"8635_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 2024;43(3):919\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"8635_CR2","doi-asserted-by":"crossref","unstructured":"Huang H, Yao Y, Deng X et al. Immunotherapy for nasopharyngeal carcinoma: current status and prospects (Review). Int J Oncol. 2023;63(2).","DOI":"10.3892\/ijo.2023.5545"},{"issue":"2","key":"8635_CR3","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.bjorl.2023.101366","volume":"90","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Fang J, Zhong Q, et al. Surgical treatment and prognosis of recurrent and radiotherapy insensitive nasopharyngeal carcinoma. Braz J Otorhinolaryngol. 2024;90(2):101366.","journal-title":"Braz J Otorhinolaryngol"},{"key":"8635_CR4","doi-asserted-by":"crossref","unstructured":"Lei M, Xu L, Wei P, Liangfangshen, Li Z. A machine learning-based predictive model for radiosensitivity in nasopharyngeal carcinoma utilizing serum proteomics. J Transl Med. 2026;24(1).","DOI":"10.1186\/s12967-026-07847-2"},{"issue":"2","key":"8635_CR5","doi-asserted-by":"publisher","first-page":"e71604","DOI":"10.1002\/cam4.71604","volume":"15","author":"Y Luo","year":"2026","unstructured":"Luo Y, Cai B, Li B, Du L, Ma L. Safety and Efficacy of Salvage Treatment for Recurrent Nasopharyngeal Carcinoma: A Single-Center Retrospective Study Over 10 Years. Cancer Med. 2026;15(2):e71604.","journal-title":"Cancer Med"},{"issue":"36","key":"8635_CR6","doi-asserted-by":"publisher","first-page":"e2403161","DOI":"10.1002\/advs.202403161","volume":"11","author":"X Wan","year":"2024","unstructured":"Wan X, Liu Y, Peng Y, et al. Primary and Orthotopic Murine Models of Nasopharyngeal Carcinoma Reveal Molecular Mechanisms Underlying its Malignant Progression. Adv Sci (Weinh). 2024;11(36):e2403161.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"8635_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.14715\/cmb\/2024.70.3.19","volume":"70","author":"M Xu","year":"2024","unstructured":"Xu M, Fan Y, Zou G, Yang Q, Xu F. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K\/AKT\/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis. Cell Mol Biol (Noisy-le-grand). 2024;70(3):130\u20135.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"8635_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12935-023-02995-7","volume":"23","author":"G Feng","year":"2023","unstructured":"Feng G, Arima Y, Midorikawa K, et al. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K\/Akt\/mTOR pathway. Cancer Cell Int. 2023;23(1):185.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"8635_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s13402-026-01166-w","volume":"49","author":"R Zeng","year":"2026","unstructured":"Zeng R, Zhong L, Li P, Gao X, Chen Y, Hao W. Akt\/mTOR pathway-mediated CCNA1 regulation of radiotherapy resistance in nasopharyngeal carcinoma. Cell Oncol (Dordr). 2026;49(1):32.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"8635_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40364-022-00397-x","volume":"10","author":"HL Li","year":"2022","unstructured":"Li HL, Deng NH, He XS, Li YH. Small biomarkers with massive impacts: PI3K\/AKT\/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma. Biomark Res. 2022;10(1):52.","journal-title":"Biomark Res"},{"key":"8635_CR11","doi-asserted-by":"crossref","unstructured":"Zhan J, J\u00fccker M. The Role of PI3K\/AKT\/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor Research. Int J Mol Sci. 2025. 26(14).","DOI":"10.3390\/ijms26146853"},{"key":"8635_CR12","doi-asserted-by":"publisher","first-page":"775238","DOI":"10.3389\/fonc.2022.775238","volume":"12","author":"L Qiao","year":"2022","unstructured":"Qiao L, Chen Y, Liang N, et al. Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies. Front Oncol. 2022;12:775238.","journal-title":"Front Oncol"},{"key":"8635_CR13","doi-asserted-by":"publisher","first-page":"156484","DOI":"10.1016\/j.phymed.2025.156484","volume":"140","author":"J Xie","year":"2025","unstructured":"Xie J, Shi Z, Sun L, et al. Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K\/AKT pathway dysregulation. Phytomedicine. 2025;140:156484.","journal-title":"Phytomedicine"},{"key":"8635_CR14","doi-asserted-by":"publisher","first-page":"155091","DOI":"10.1016\/j.prp.2024.155091","volume":"254","author":"HS Chawra","year":"2024","unstructured":"Chawra HS, Agarwal M, Mishra A, et al. MicroRNA-21\u2019s role in PTEN suppression and PI3K\/AKT activation: Implications for cancer biology. Pathol Res Pract. 2024;254:155091.","journal-title":"Pathol Res Pract"},{"key":"8635_CR15","doi-asserted-by":"publisher","first-page":"1279822","DOI":"10.3389\/fonc.2023.1279822","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang T, He X. Advances in the role of microRNAs associated with the PI3K\/AKT signaling pathway in lung cancer. Front Oncol. 2023;13:1279822.","journal-title":"Front Oncol"},{"issue":"12","key":"8635_CR16","doi-asserted-by":"publisher","first-page":"e0225660","DOI":"10.1371\/journal.pone.0225660","volume":"14","author":"P Maiti","year":"2019","unstructured":"Maiti P, Plemmons A, Dunbar GL. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K\/Akt\/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments. PLoS ONE. 2019;14(12):e0225660.","journal-title":"PLoS ONE"},{"key":"8635_CR17","doi-asserted-by":"publisher","first-page":"1695200","DOI":"10.3389\/fphar.2025.1695200","volume":"16","author":"SW Smail","year":"2025","unstructured":"Smail SW, Bergsten P, Taha KO, et al. Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer. Front Pharmacol. 2025;16:1695200.","journal-title":"Front Pharmacol"},{"key":"8635_CR18","doi-asserted-by":"crossref","unstructured":"Duda-Madej A, Viscardi S, Szewczyk W, Topola E. Natural Alkaloids in Cancer Therapy: Berberine, Sanguinarine and Chelerythrine against Colorectal and Gastric Cancer. Int J Mol Sci. 2024. 25(15).","DOI":"10.3390\/ijms25158375"},{"issue":"10","key":"8635_CR19","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.7150\/ijbs.114373","volume":"21","author":"S Liu","year":"2025","unstructured":"Liu S, Zhang R, Liu Y, Lin X, Chen J. Cancer patient-derived organoids: Novel models for the study of natural products. Int J Biol Sci. 2025;21(10):4485\u2013503.","journal-title":"Int J Biol Sci"},{"key":"8635_CR20","doi-asserted-by":"crossref","unstructured":"Lin Y, Zhang Q, Xie B et al. Chelerythrine-Induced Apoptotic Cell Death in HepG2 Cells Involves the Inhibition of Akt Pathway and the Activation of Oxidative Stress and Mitochondrial Apoptotic Pathway. Antioxid (Basel). 2022. 11(9).","DOI":"10.3390\/antiox11091837"},{"issue":"4","key":"8635_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3892\/br.2025.1938","volume":"22","author":"YT Wu","year":"2025","unstructured":"Wu YT, Chen LC, Wang HH, et al. Scutellarein enhances cisplatin\u2013induced apoptotic effects by suppressing the PI3K\/AKT\u2013MDR1 pathway in human NPC\/HK1 nasopharyngeal carcinoma cells. Biomed Rep. 2025;22(4):60.","journal-title":"Biomed Rep"},{"key":"8635_CR22","doi-asserted-by":"publisher","first-page":"106568","DOI":"10.1016\/j.phrs.2022.106568","volume":"187","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Mirdamadi M, Talebi Y, et al. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res. 2023;187:106568.","journal-title":"Pharmacol Res"},{"issue":"12","key":"8635_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1080\/15384101.2022.2046983","volume":"21","author":"S Fang","year":"2022","unstructured":"Fang S, Wang L, Luo C, Yi H, Wang X, Ning B. Curcumol inhibits the growth of xenograft-tumors in mice and the biological activities of pancreatic cancer cells by regulating the miR-21-5p\/SMAD7 axis. Cell Cycle. 2022;21(12):1249\u201366.","journal-title":"Cell Cycle"},{"key":"8635_CR24","doi-asserted-by":"crossref","unstructured":"Heng WS, Cheah SC. Chelerythrine Chloride Downregulates \u03b2-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma. Molecules. 2020. 25(1).","DOI":"10.3390\/molecules25010224"},{"issue":"1","key":"8635_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1186\/s12967-025-07025-w","volume":"23","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang Z, Zhao H, et al. Chelerythrine inhibits esophageal squamous cell carcinoma progression via PINK1-Parkin-mediated mitophagy. J Transl Med. 2025;23(1):1116.","journal-title":"J Transl Med"},{"key":"8635_CR26","doi-asserted-by":"publisher","first-page":"104965","DOI":"10.1016\/j.tiv.2020.104965","volume":"68","author":"T Yang","year":"2020","unstructured":"Yang T, Xu R, Su Q, et al. Chelerythrine hydrochloride inhibits proliferation and induces mitochondrial apoptosis in cervical cancer cells via PI3K\/BAD signaling pathway. Toxicol Vitro. 2020;68:104965.","journal-title":"Toxicol Vitro"},{"issue":"1\u20132","key":"8635_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-020-03845-0","volume":"474","author":"B Yang","year":"2020","unstructured":"Yang B, Zhang D, Qian J, Cheng Y. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP\/TIMP\/NF-\u03baB system. Mol Cell Biochem. 2020;474(1\u20132):199\u2013208.","journal-title":"Mol Cell Biochem"},{"key":"8635_CR28","doi-asserted-by":"publisher","first-page":"906301","DOI":"10.3389\/fphar.2022.906301","volume":"13","author":"N Chen","year":"2022","unstructured":"Chen N, Qi Y, Ma X, et al. Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine. Front Pharmacol. 2022;13:906301.","journal-title":"Front Pharmacol"},{"key":"8635_CR29","doi-asserted-by":"crossref","unstructured":"Hiruma K, Bilim V, Kazama A, Shirono Y, Murata M, Tomita Y. Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP. Curr Issues Mol Biol. 2025. 47(1).","DOI":"10.3390\/cimb47010043"},{"issue":"4","key":"8635_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.7150\/ijms.92182","volume":"21","author":"B Kou","year":"2024","unstructured":"Kou B, Shi Y, Zhou Z, et al. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1\/AMPK signaling. Int J Med Sci. 2024;21(4):623\u201332.","journal-title":"Int J Med Sci"},{"issue":"1","key":"8635_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1248\/bpb.b17-00451","volume":"41","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Pan Y, Zhang G, et al. Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis in Vitro. Biol Pharm Bull. 2018;41(1):36\u201346.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"8635_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12885-025-13965-9","volume":"25","author":"P Golestannejad","year":"2025","unstructured":"Golestannejad P, Monkaresi M, Zhian Zargaran F, et al. Role of Cancer Associated Fibroblast (CAF) derived miRNAs on head and neck malignancies microenvironment: a systematic review. BMC Cancer. 2025;25(1):582.","journal-title":"BMC Cancer"},{"issue":"6","key":"8635_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.17219\/acem\/146580","volume":"31","author":"H Luo","year":"2022","unstructured":"Luo H, Zhong F, Jing X, Lin H, Li Y. miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy. Adv Clin Exp Med. 2022;31(6):671\u201387.","journal-title":"Adv Clin Exp Med"},{"issue":"26","key":"8635_CR34","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/onc.2015.402","volume":"35","author":"CF Yang","year":"2016","unstructured":"Yang CF, Yang GD, Huang TJ, et al. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K\/AKT pathway by a positive feedback loop. Oncogene. 2016;35(26):3419\u201331.","journal-title":"Oncogene"},{"key":"8635_CR35","doi-asserted-by":"crossref","unstructured":"Shakerdi AL, Finnegan E, Sheng YY, Pidgeon GP. The Multifaceted Role of Autophagy in Nasopharyngeal Carcinoma: Translational Perspectives on Pathogenesis, Biomarkers, Treatment Resistance, and Emerging Therapies. Cancers (Basel). 2025. 17(15).","DOI":"10.3390\/cancers17152577"},{"key":"8635_CR36","doi-asserted-by":"crossref","unstructured":"Jiang M, Zhang K, Zhang Z et al. PI3K\/AKT\/mTOR Axis in Cancer: From Pathogenesis to Treatment. MedComm (2020). 2025;6(8): e70295.","DOI":"10.1002\/mco2.70295"},{"key":"8635_CR37","doi-asserted-by":"publisher","first-page":"121559","DOI":"10.1016\/j.lfs.2023.121559","volume":"320","author":"O Cho","year":"2023","unstructured":"Cho O, Lee JW, Kim HS, Jeong YJ, Heo TH. Chelerythrine, a novel small molecule targeting IL-2, inhibits melanoma progression by blocking the interaction between IL-2 and its receptor. Life Sci. 2023;320:121559.","journal-title":"Life Sci"},{"key":"8635_CR38","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.2147\/IJN.S523213","volume":"20","author":"T Wang","year":"2025","unstructured":"Wang T, Wu H, Wang L, Lou N, Guo L. Targeted Nanoparticle-Based Therapies for Nasopharyngeal Carcinoma: Enhancing Radiosensitization, Photothermal Therapy, and Diagnostics. Int J Nanomed. 2025;20:7021\u201335.","journal-title":"Int J Nanomed"},{"issue":"1","key":"8635_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7150\/thno.116136","volume":"16","author":"KY Lee","year":"2026","unstructured":"Lee KY, Sun H, Mei Y, et al. Development of a nanoparticle-based immunotherapy targeting CD137 for nasopharyngeal carcinoma treatment. Theranostics. 2026;16(1):17\u201336.","journal-title":"Theranostics"},{"key":"8635_CR40","doi-asserted-by":"publisher","first-page":"935205","DOI":"10.3389\/fcimb.2022.935205","volume":"12","author":"T Yang","year":"2022","unstructured":"Yang T, You C, Meng S, Lai Z, Ai W, Zhang J. EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis. Front Cell Infect Microbiol. 2022;12:935205.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08635-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08635-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08635-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:56:59Z","timestamp":1791255419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08635-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8635"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08635-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Hunan University of Chinese Medicine (Ethics code: LL2023030804). The animal studies were conducted in strict accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH, USA) to ensure animal welfare and minimize suffering.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1250"}}